APLASTIC ANEMIA
Clinical trials for APLASTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new APLASTIC ANEMIA trials appear
Sign up with your email to follow new studies for APLASTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cord blood cells aim to break transfusion dependence in aplastic anemia
Disease control Not yet recruitingThis study tests a new treatment called CK0801 for adults with aplastic anemia who still need blood transfusions after standard therapy. CK0801 uses immune cells from donated cord blood to help the body make its own blood cells again. The goal is to see if it is safe and can redu…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Cellenkos, Inc. • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
New hope for patients with treatment-resistant anemia after chemo or radiation
Disease control Not yet recruitingThis study tests a drug called romiplostim N01 in 43 adults with aplastic anemia caused by chemotherapy or radiation that did not improve with standard treatments. The goal is to see if the drug can help the bone marrow produce more blood cells and improve blood counts. Participa…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New hope for rare blood disorder: daratumumab trial targets refractory aplastic anemia
Disease control Not yet recruitingThis study tests a drug called daratumumab in people with aplastic anemia that hasn't improved with standard treatments. The goal is to see if it is safe and can help the body make more blood cells. About 37 participants will receive multiple doses, and researchers will check for…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New hope for kids with rare bone marrow failure: drug combo aims to restore blood cells
Disease control Not yet recruitingThis study tests whether adding romiplostim to standard immunosuppressive therapy helps children and young adults (ages 2–21) with severe aplastic anemia produce healthy blood cells. Participants have either newly diagnosed or hard-to-treat disease. The main goal is to see if blo…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Anjali Sharathkumar • Aim: Disease control
Last updated May 12, 2026 13:42 UTC